F.A. Căruntu *
F.A. Căruntu, asistent universitar, Clinica a II-a de boli infecțioase “Colentina”, UMF “Carol Davila”, București
Article information. Therapeutical Practice · Ther Pharmacol Clin Toxicol 1997;1(2):108–111 · Article in Romanian with an English abstract
Abstract
Ceftibuten (Cedax®), a new oral cephalosporine of third generation, with a once-daily dosing regime, has the qualities of a modern antibiotic. Ceftibuten represents the beginning of a strategy which has adopted pharmacokinetic principles to optimise antibiotic therapy. It has been developed like a broad-spectrum antibiotic stable to betalactamases, active against the main respiratory and urinary tract pathogens. Due to its excellent compliance and tolerability Cedax® is successfully used in the treatment of common respiratory and urinary tract infections in both pediatric and adult patients.
Keywords: Ceftibuten (Cedax®); optimising antibiotic therapy
Cite as: Căruntu FA. Optimizarea tratamentului antibiotic prin Cedax® (ceftibuten-DCI). Ther Pharmacol Clin Toxicol. 1997;1(2):108–111.